Savino Bruno
Savino Bruno
Professor of Medicine, Humanitas University
Verified email at
TitleCited byYear
Boceprevir for untreated chronic HCV genotype 1 infection
F Poordad, J McCone Jr, BR Bacon, S Bruno, MP Manns, MS Sulkowski, ...
New England Journal of Medicine 364 (13), 1195-1206, 2011
Sustained virological response to interferon‐α is associated with improved outcome in HCV‐related cirrhosis: A retrospective study
S Bruno, T Stroffolini, M Colombo, S Bollani, L Benvegnu, G Mazzella, ...
Hepatology 45 (3), 579-587, 2007
Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study
S Bruno, E Silini, A Crosignani, F Borzio, G Leandro, F Bono, M Asti, ...
Hepatology 25 (3), 754-758, 1997
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis
X Liu, P Invernizzi, Y Lu, R Kosoy, Y Lu, I Bianchi, M Podda, C Xu, G Xie, ...
Nature genetics 42 (8), 658, 2010
Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections
B Oliviero, S Varchetta, E Paudice, G Michelone, M Zaramella, D Mavilio, ...
Gastroenterology 137 (3), 1151-1160. e7, 2009
Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities
E Silini, F Bono, A Cividini, A Cerino, S Bruno, S Rossi, G Belloni, ...
Hepatology 21 (2), 285-290, 1995
The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis
B Palmentieri, I De Sio, V La Mura, M Masarone, R Vecchione, S Bruno, ...
Digestive and Liver Disease 38 (7), 485-489, 2006
Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study
M Borzio, S Bruno, M Roncalli, GC Mels, G Ramella, F Borzio, G Leandro, ...
Gastroenterology 108 (3), 812-817, 1995
Sustained virologic response prevents the development of esophageal varices in compensated, Child‐Pugh class A hepatitis C virus–induced cirrhosis. A 12‐year prospective followá…
S Bruno, A Crosignani, C Facciotto, S Rossi, L Roffi, A Redaelli, ...
Hepatology 51 (6), 2069-2076, 2010
Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study
E Silini, R Bottelli, M Asti, S Bruno, ME Candusso, S Brambilla, F Bono, ...
Gastroenterology 111 (1), 199-205, 1996
Prevalence and etiology of altered liver tests: a population‐based survey in a Mediterranean town
GM Pendino, A Mariano, P Surace, CA Caserta, MT Fiorillo, A Amante, ...
Hepatology 41 (5), 1151-1159, 2005
Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis
S Raimondi, S Bruno, MU Mondelli, P Maisonneuve
Journal of hepatology 50 (6), 1142-1154, 2009
Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C
C CammÓ, S Bruno, V Di Marco, D Di Bona, M Rumi, M Vinci, C Rebucci, ...
Hepatology 43 (1), 64-71, 2006
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients
M Pietrogrande, S De Vita, AL Zignego, P Pioltelli, D Sansonno, S Sollima, ...
Autoimmunity reviews 10 (8), 444-454, 2011
Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen‐year prospective cohort study
S Bruno, A Crosignani, P Maisonneuve, S Rossi, E Silini, MU Mondelli
Hepatology 46 (5), 1350-1356, 2007
Repeated paracentesis and iv albumin infusion to treat ‘tense’ascites in cirrhotic patients: a safe alternative therapy
F Salerno, S Badalamenti, P Incerti, S Tempini, B Restelli, S Bruno, ...
Journal of Hepatology 5 (1), 102-108, 1987
Efficacy and safety of peginterferon alfa‐2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis
S Bruno, ML Shiffman, SK Roberts, EJ Gane, D Messinger, ...
Hepatology 51 (2), 388-397, 2010
Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial
S Bruno, P Maisonneuve, P Castellana, N Rotmensz, S Rossi, ...
bmj 330 (7497), 932, 2005
Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study
S Bruno, M Zuin, A Crosignani, S Rossi, F Zadra, L Roffi, M Borzio, ...
The American journal of gastroenterology 104 (5), 1147, 2009
Human leukocyte antigen class II and III alleles and severity of hepatitis C virus–related chronic liver disease
M Asti, M Martinetti, C Zavaglia, MC Cuccia, L Gusberti, C Tinelli, ...
Hepatology 29 (4), 1272-1279, 1999
The system can't perform the operation now. Try again later.
Articles 1–20